Japan Launches Groundbreaking Treatment Using Reprogrammed Cells
Wired
Japan has approved the first-ever treatments using reprogrammed human cells, marking a revolutionary step in regenerative medicine. Discover what this means for the future.
Japan grants first approval for iPS cell-derived treatments.
ReHeart offers hope for severe heart failure patients.
Amusepri aims to improve motor symptoms in Parkinson's disease.
Breakthroughs in regenerative medicine may reshape treatment options.